{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreia2vvfjnhmsmcq4vu4yvchn4niikzi6dbnamka65vkgulthqkw6sa",
    "uri": "at://did:plc:5ka4qkui7nvjms7idhte2m4o/app.bsky.feed.post/3mgn733uda4x2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreid3sq7meogdlkimyqrg7oxzt4jbyo3lbvjt742yzs6vs66b3uozje"
    },
    "mimeType": "image/jpeg",
    "size": 59109
  },
  "path": "/2026/03/09/novo-nordisk-wegovy-hims-hers-deal/?utm_campaign=rss",
  "publishedAt": "2026-03-09T13:23:21.000Z",
  "site": "https://www.statnews.com",
  "tags": [
    "Breaking News",
    "Health tech",
    "Pharma",
    "biotechnology",
    "Novo Nordisk",
    "Obesity",
    "Pharmaceuticals",
    "STAT+",
    "Telehealth",
    "weight loss"
  ],
  "textContent": "Novo Nordisk and Hims & Hers have reached a deal that, for now, appears to end their bitter dispute around Hims’ sale of compounded versions of Novo’s blockbuster obesity drug…",
  "title": "STAT+: Novo Nordisk, Hims reach deal to end bitter dispute over Wegovy sales",
  "updatedAt": "2026-03-09T15:33:00.000Z"
}